| Net sales | 2.37B |
| Cost of sales | 1.58B |
| Gross profit | 788.4M |
| Selling, general and administrative expenses | 400.5M |
| Amortization of intangibles and other assets | 41.1M |
| Restructuring and other special charges | 22.8M |
| Operating income | 324M |
| Interest expense | -58.2M |
| Equity method income, net | 2.6M |
| Investment income | 600K |
| Other, net | -5.6M |
| Earnings before income taxes | |
| Provision for income taxes | 83.6M |
| Net earnings | 179.8M |
| Less: Net earnings attributable to the noncontrolling interest | -300K |
| Net earnings attributable to Laboratory Corporation of America Holdings | 179.5M |
| Basic earnings per common share | 1.74 |
| Diluted earnings per common share | 1.71 |